The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Trastuzumab pamirtecan, being developed under a 2023 partnership between BioNTech and DualityBio, elicited a 44.1% overall ...

Researchers found that pancreatic pre-cancer cells mimic dementia by forming clumps of proteins due to faulty recycling processes. These insights could shed light on why pancreatic cancer develops so ...

A new study led by researchers at the University of Liège highlights the unexpected role of Stard7 in the development of intestinal cancers.

Researchers at the University of Chicago have developed a modular cancer immunotherapy that can be switched on, off or reprogramed to attack different cancers. Promising initial testing results, ...

Trudy Oliver, professor of pharmacology and cancer biology, is part of a team of scientists that recently published a study uncovering a major shift in how scientists understand small-cell lung cancer ...

The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system ...